These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 30698734)

  • 41. Cause of mortality in 5-year survivors of childhood cancer.
    Mertens AC
    Pediatr Blood Cancer; 2007 Jun; 48(7):723-6. PubMed ID: 17226844
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Patterns of Cause-Specific Mortality Among 2053 Survivors of Retinoblastoma, 1914-2016.
    Kleinerman RA; Tucker MA; Sigel BS; Abramson DH; Seddon JM; Morton LM
    J Natl Cancer Inst; 2019 Sep; 111(9):961-969. PubMed ID: 30698734
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Cause-specific mortality in long-term survivors of retinoblastoma.
    Yu CL; Tucker MA; Abramson DH; Furukawa K; Seddon JM; Stovall M; Fraumeni JF; Kleinerman RA
    J Natl Cancer Inst; 2009 Apr; 101(8):581-91. PubMed ID: 19351917
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Risk of second malignancies in survivors of retinoblastoma: more than 40 years of follow-up.
    Marees T; Moll AC; Imhof SM; de Boer MR; Ringens PJ; van Leeuwen FE
    J Natl Cancer Inst; 2008 Dec; 100(24):1771-9. PubMed ID: 19066271
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Cancer mortality in long-term survivors of retinoblastoma.
    Marees T; van Leeuwen FE; de Boer MR; Imhof SM; Ringens PJ; Moll AC
    Eur J Cancer; 2009 Dec; 45(18):3245-53. PubMed ID: 19493675
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Long-term cause-specific mortality in survivors of adolescent and young adult bone and soft tissue sarcoma: a population-based study of 28,844 patients.
    Youn P; Milano MT; Constine LS; Travis LB
    Cancer; 2014 Aug; 120(15):2334-42. PubMed ID: 24752471
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Risk of soft tissue sarcomas by individual subtype in survivors of hereditary retinoblastoma.
    Kleinerman RA; Tucker MA; Abramson DH; Seddon JM; Tarone RE; Fraumeni JF
    J Natl Cancer Inst; 2007 Jan; 99(1):24-31. PubMed ID: 17202110
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Risks of Melanoma and Other Cancers in Melanoma-Prone Families over 4 Decades.
    Tucker MA; Elder DE; Curry M; Fraser MC; Pichler V; Zametkin D; Yang XR; Goldstein AM
    J Invest Dermatol; 2018 Jul; 138(7):1620-1626. PubMed ID: 29408205
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Second primary malignancies in retinoblastoma patients treated with intra-arterial chemotherapy: the first 10 years.
    Habib LA; Francis JH; Fabius AW; Gobin PY; Dunkel IJ; Abramson DH
    Br J Ophthalmol; 2018 Feb; 102(2):272-275. PubMed ID: 28600304
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Long term cause specific mortality among 34 489 five year survivors of childhood cancer in Great Britain: population based cohort study.
    Fidler MM; Reulen RC; Winter DL; Kelly J; Jenkinson HC; Skinner R; Frobisher C; Hawkins MM;
    BMJ; 2016 Sep; 354():i4351. PubMed ID: 27586237
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Incidence of second cancers after radiotherapy and systemic chemotherapy in heritable retinoblastoma survivors: A report from the German reference center.
    Temming P; Arendt M; Viehmann A; Eisele L; Le Guin CH; Schündeln MM; Biewald E; Astrahantseff K; Wieland R; Bornfeld N; Sauerwein W; Eggert A; Jöckel KH; Lohmann DR
    Pediatr Blood Cancer; 2017 Jan; 64(1):71-80. PubMed ID: 27567086
    [TBL] [Abstract][Full Text] [Related]  

  • 52. How Eye-Preserving Therapy Affects Long-Term Overall Survival in Heritable Retinoblastoma Survivors.
    Temming P; Arendt M; Viehmann A; Eisele L; Le Guin CH; Schündeln MM; Biewald E; Mäusert J; Wieland R; Bornfeld N; Sauerwein W; Eggert A; Lohmann DR; Jöckel KH
    J Clin Oncol; 2016 Sep; 34(26):3183-8. PubMed ID: 27382102
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Treatment of Retinoblastoma in 2015: Agreement and Disagreement.
    Abramson DH; Shields CL; Munier FL; Chantada GL
    JAMA Ophthalmol; 2015 Nov; 133(11):1341-7. PubMed ID: 26378747
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Whole-exome sequencing of pancreatic cancer defines genetic diversity and therapeutic targets.
    Witkiewicz AK; McMillan EA; Balaji U; Baek G; Lin WC; Mansour J; Mollaee M; Wagner KU; Koduru P; Yopp A; Choti MA; Yeo CJ; McCue P; White MA; Knudsen ES
    Nat Commun; 2015 Apr; 6():6744. PubMed ID: 25855536
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Risk of subsequent malignant neoplasms in long-term hereditary retinoblastoma survivors after chemotherapy and radiotherapy.
    Wong JR; Morton LM; Tucker MA; Abramson DH; Seddon JM; Sampson JN; Kleinerman RA
    J Clin Oncol; 2014 Oct; 32(29):3284-90. PubMed ID: 25185089
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Breast cancer risk after radiotherapy for heritable and non-heritable retinoblastoma: a US-UK study.
    Little MP; Schaeffer ML; Reulen RC; Abramson DH; Stovall M; Weathers R; de Vathaire F; Diallo I; Seddon JM; Hawkins MM; Tucker MA; Kleinerman RA
    Br J Cancer; 2014 May; 110(10):2623-32. PubMed ID: 24755883
    [TBL] [Abstract][Full Text] [Related]  

  • 57.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 58.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 59.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.